Development of tumor-targeted near infrared probes for fluorescence guided surgery

Bioconjugate Chemistry

Volumn 24, Issue 6, 2013, Pages 1075-1080

  Kelderhouse, Lindsay E ^a   Chelvam, Venkatesh ^a   Wayua, Charity ^a   Mahalingam, Sakkarapalayam ^a   Poh, Scott ^a   Kularatne, Sumith A ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; HISTOLOGY; INFRARED DEVICES; LIGANDS; PROBES; SURGERY; TUMORS;

CANCER CELLS; FOLATE RECEPTOR; GUIDED SURGERY; HEALTHY TISSUES; INFRARED PROBES; MALIGNANT DISEASE; NEAR INFRARED; NEAR-INFRARED; PROSTATE-SPECIFIC MEMBRANE ANTIGENS; TARGETING LIGANDS;

FLUORESCENCE;

FLUORESCENT DYE; FOLATE RECEPTOR; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER SURGERY; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PROCESS DEVELOPMENT; RECEPTOR AFFINITY; RECEPTOR BINDING;

MUS;

EID: 84879355672     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc400131a     Document Type: Article

References (38)

1. De Grand, A. M. and Frangioni, J. V. (2003) An operational near-infrared fluorescence imaging system prototype for large animal surgery Technol. Cancer Res. Treat. 2, 553-562
2. Griffiths, C. T. (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma J. Natl. Cancer Inst. Monogr. 42, 101-104
3. Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., and Montz, F. J. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis J. Clin. Oncol. 20, 1248-1259
4. Karakiewicz, P. I., Eastham, J. A., Graefen, M., Cagiannos, I., Stricker, P. D., Klein, E., Cangiano, T., Schroder, F. H., Scardino, P. T., and Kattan, M. W. (2005) Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients Urology 66, 1245-1250
5. Kapp, K. S., Kapp, D. S., Poschauko, J., Stucklschweiger, G. F., Hackl, A., Pickel, H., Petru, E., and Winter, R. (1999) The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy and radiotherapy Gynecol. Oncol. 74, 400-407
6. Kitai, T., Inomoto, T., Miwa, M., and Shikayama, T. (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer Breast Cancer 12, 211-215
7. Tagaya, N., Yamazaki, R., Nakagawa, A., Abe, A., Hamada, K., Kubota, K., and Oyama, T. (2008) Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with break cancer Am. J. Surg. 195, 850-853
8. Fujiwara, M., Mizukami, T., Suzuki, A., and Fukamizu, H. (2009) Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience J. Plast. Reconstr. Aesthet. Surg. 62, E373-E378
9. Ogasawara, Y., Ikeda, H., Takahashi, M., Kawasaki, K., and Doihara, H. (2008) Evaluation of breast lympathic pathways with indocyanine green fluorescence imaging in patients with breast cancer World J. Surg. 32, 1924-1929
10. Bristow, R. E. (2000) Surgical standards in the management of ovarian cancer Curr. Opin. Oncol. 12, 474-480
11. Rubin, S. C., Randall, T. C., Armstrong, K. A., Chi, D. S., and Hoskins, W. J. (1999) Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings Obstet. Gynecol. 93, 21-24
12. Yossepowitch, O., Bjartell, A., Eastham, J. A., Graefen, M., Guillonneau, B. D., Karakiewicz, P. I., Montironi, R., and Montorsi, F. (2009) Positive surgical margins in radical prostatectomy: Outlining the problem and its long-term consequences Eur. Urol. 55, 87-99
13. Khoury-Collado, F. and Chi, D. S. (2011) Recent surgical management of ovarian cancer J. Obstet. Gynaecol. Res. 37, 379-382
14. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A., Jr. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat. Biotechnol. 17, 375-387
15. Urano, Y., Asanuma, D., and Hama, Y. (2009) Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes Nat. Med. 15, 104-109
16. Mahmood, U. and Weissleder, R. (2003) Near-infrared optical imaging of proteases in cancer Mol. Cancer Ther. 2, 489-496
17. Hama, Y., Urano, Y., Koyama, Y., Gunn, J. R., Choyke, P. L., and Kobayashi, H. (2007) A self-quenched galactosamine-serum albumin-rhodamineX conjugate a 'smart' fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases Clin. Cancer Res. 13, 6335-6343
18. Ogawa, M., Kosaka, N., Choyke, P. L., and Kobayashi, H. (2009) In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green Cancer Res. 69, 1268-1272
19. Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., and Tung, C. H. (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model Radiology 221, 523-529
20. Mahmood, U., Tung, C. H., Bogdanov, A., Jr., and Weissleder, R. (1999) Near-infrared optical imaging of protease activity for tumor detection Radiology 213, 866-870
21. Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., and Leamon, C. P. (2005) Folate receptor expression in carcinomas and normal tissues determine by a quantitative radioligand binding assay Anal. Biochem. 338, 284-293
22. Xia, W. and Low, P. S. (2010) Folate-targeted therapies for cancer J. Med. Chem. 53, 6811-6824
23. Kularatne, S. A., Wang, K., Santhapuram, H. K. R., and Low, P. S. (2009) Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand Mol. Pharmaceutics 6, 780-789
24. 99mTc-radioimaging agents Mol. Pharmaceutics 6, 790-800
25. Chang, S. S., Reuter, V. E., Heston, W. D., Bander, N. H., Grauer, L. S., and Gaudin, P. B. (1999) Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature Cancer Res. 59, 3192-3198
26. van Dam, G. M., Themelis, G., Crane, L. M., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J., van der Zee, A. G., Bart, J., Low, P. S., and Ntziachristo, V. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results Nat. Med. 17, 1315-1320
27. Kennedy, M. D., Jallad, K. N., Thompson, D. H., Ben-Amotz, D., and Low, P. S. (2003) Optical imaging of metastatic tumors using a folate-targeted fluorescent probe J. Biomed. Opt. 8, 636-641
28. Leamon, C. P., Reddy, J. A., Vlahov, I. R., Westrick, W., Parker, N., Nicoson, J. S., and Vetzel, M. (2007) Comparative preclinical activity of the folate-targeted vinca alkalois conjugates EC140 and EC145 Int. J. Cancer. 121, 1585-1592
29. Leamon, C. P., Reddy, J. A., Vlahov, I. R., Kleindl, P. J., Vetzel, M., and Westrick, E. (2006) Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate Bioconjugate Chem. 17, 1226-1232
30. Vlahov, I. R., Santhapuram, H. K., Kleindl, P. J., Howard, S. J., Stanford, K. M., and Leamon, C. P. (2006) Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1, EC145, a folic acid conjugate of desacetylvinblastine monohydrazide Bioorg. Med. Chem. Lett. 16, 5093-5096
31. Lu, Y. and Low, P. S. (2002) Folate targeting of haptens to cancer cell surfaces mediated immunotherapy of syngeneic murine tumors Cancer Immunol. Immunother. 51, 153-162
32. Zhu, L., Zhang, F., Ma, Y., Liu, G., Kim, K., Fang, X., Lee, S., and Chen, X. (2011) In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity Mol. Pharmaceutics 8, 2331-2338
33. Tung, C. H., Bredow, S., Mahmood, U., and Weissleder, R. (1999) Preparation of a cathepsin D senative near-infrared fluorescence probe for imaging Bioconjugate Chem. 10, 892-896
34. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 7, 743
35. Tung, C. H., Mahmood, U., Bredow, S., and Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter Cancer Res. 60, 4953-4958
36. Tung, C. H. (2004) Fluorescent peptide probes for in vivo diagnostic imaging Biopolymers 76, 391-403
37. Nguyen, Q. T., Olson, E. S., Aguilera, T. A., Jiang, T., Scadeng, M., Ellies, L. G., and Tsien, R. Y. (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival Proc. Natl. Acad. Sci. U.S.A. 107, 4317-4322
38. Bremer, C., Tung, C. H., Bogdanov, A., and Weissleder, R. (2002) Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes Radiology 222, 814-818